Potential Health Risks of Snus: A Popular Tobacco Alternative

Industry Insight by 2FIRSTS.ai
Jan.08.2024
Potential Health Risks of Snus: A Popular Tobacco Alternative
Snus, a popular tobacco alternative, is facing health concerns as experts warn of potential risks.

According to a recent report by LadBible, an alternative product called Snus (a tobacco-filled pouch) is gaining popularity, but experts are warning of potential health risks associated with this product. For those unfamiliar with this term, Snus is essentially a tobacco product that resembles small tea bags.

 

Snus, originating from Northern Europe, has been widely popular there and has actually become the most common type of tobacco product in Norway. It is also gaining increasing popularity among young people. However, in all European Union countries, as well as Australia and New Zealand, Snus is even illegal.

 

This small tobacco pouch is placed under a person's lip for approximately thirty minutes, often likened to a disposable tea bag. However, due to its nicotine content, Snus can be addictive.

 

Toxicology management consultant Libby Clarke has informed the media that the absorption of nicotine through oral products is slower compared to smoking cigarettes or e-cigarettes, suggesting that their potential for addiction may be lower.

 

However, a London dentist has warned on social media that using Snus by placing it on the gums may cause harm to the mouth, leading to gum disease and gingivitis, and possibly even pre-cancerous conditions. Currently, there is not a lot of data on the safety of Snus, but in theory, this product should be better than cigarettes, although it still poses health risks.

 

Pharmacist Ian Budd added that due to the presence of nicotine, Snus is considered an addictive substance, which is what initially leads to smoking addiction. Certain studies have indicated a potential correlation between Snus usage and higher rates of pancreatic cancer, heart failure, and diabetes, although research on this matter is still ongoing.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

The U.S. FDA has issued two notices: seeking public comments on regulations regarding tobacco retailer training programs and sales restrictions
The U.S. FDA has issued two notices: seeking public comments on regulations regarding tobacco retailer training programs and sales restrictions
On August 22, the U.S. FDA issued two notices soliciting public comments on regulations regarding tobacco retailer training programs and restrictions on tobacco sales. Both notices provide a 60-day public comment period under the Paperwork Reduction Act, aiming to protect public health, especially that of children and adolescents, by regulating retailer behavior and restricting tobacco sales.
Aug.22 by 2FIRSTS.ai
The Russian government approved a bill requiring e-cigarette and cigarette sales to be licensed from March 2026
The Russian government approved a bill requiring e-cigarette and cigarette sales to be licensed from March 2026
The Russian government has approved a bill submitted to the State Duma that proposes implementing a licensing system for the sale of cigarettes and e-cigarettes, covering wholesale, retail, and delivery, starting March 1, 2026. Sales to minors could result in license revocation, and large-scale illegal trading would face criminal penalties.
Sep.28 by 2FIRSTS.ai
Special Report | Russian Government Hesitates to Choke Revenue Stream with Vape Sales Ban
Special Report | Russian Government Hesitates to Choke Revenue Stream with Vape Sales Ban
Caught between banning and not banning, the Russian government finds itself in a dilemma. The vape market generates substantial tax revenue, yet raises public health concerns. Lawmakers are applying pressure—some even suggest “following China”—as a regulatory storm quietly gathers.
Aug.22
DARE Warns Malaysia: Vaping Bans Will Expand Illicit Market; Strengthen Enforcement Within Existing Framework
DARE Warns Malaysia: Vaping Bans Will Expand Illicit Market; Strengthen Enforcement Within Existing Framework
Malaysia’s policy think tank Datametrics Research and Information Sdn Bhd (DARE) cautions that state- or nationwide bans on e-cigarettes would fuel the illicit market, weaken investor confidence, reduce tax revenues, and cost jobs. DARE argues that authorities should prioritize consistent enforcement under existing laws rather than impose new prohibitions.
Sep.28 by 2FIRSTS.ai
A joint operation by multiple departments in Brazil seized 20 boxes of illegal e-cigarettes worth about $90,000
A joint operation by multiple departments in Brazil seized 20 boxes of illegal e-cigarettes worth about $90,000
Brazilian federal police, border patrol, and military jointly seize 20 crates of illegal e-cigarettes in Altônia National Park.
Sep.18 by 2FIRSTS.ai
Philip Morris International U.S. White Paper: Misconceptions About Nicotine Among Medical Professionals, FDA Urged to Strengthen Public Education on “Smoke-Free Alternatives”
Philip Morris International U.S. White Paper: Misconceptions About Nicotine Among Medical Professionals, FDA Urged to Strengthen Public Education on “Smoke-Free Alternatives”
Philip Morris International’s U.S. affiliate (PMI America) has released a new white paper stating that U.S. healthcare professionals hold serious misconceptions about smoke-free products, with nearly half incorrectly believing that nicotine causes cancer. As a result, smokers are being denied scientifically accurate harm-reduction advice. The report calls on the U.S. Food and Drug Administration (FDA) to deliver accurate information on smoke-free alternatives to physicians, so they can help adul
Aug.19 by 2FIRSTS.ai